Moderna (MRNA) PT Raised to $299 at Goldman Sachs; Sees Upside to 2022 Projections
Tweet Send to a Friend
(Updated - July 19, 2021 7:35 AM EDT)Goldman Sachs analyst Salveen Richter raised the price target on Moderna (NASDAQ: MRNA) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
